Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Vaccine Efficacy
37%
Single Cell Analysis
37%
Cytotoxic T-Cell
30%
Rebound
27%
T Cell
26%
Monospecific Antibody
25%
Adoptive Immunity
22%
Neutralizing Antibody
22%
TLR9
20%
Agonist
20%
Immunogenicity
18%
Antigen
18%
DNA Methylation
18%
Plasmacytoid Dendritic Cell
18%
Epigenetics
18%
CD47
18%
Immunocompetent Cell
18%
Cytotoxicity
18%
Cell Activation
18%
Lefitolimod
16%
Human Immunodeficiency Virus
14%
Blood Plasma
10%
Viral Load
9%
Interferon Type I
7%
Interferon-Stimulated Gene
7%
Transcriptomics
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
37%
Toll Like Receptor 9
27%
Placebo
18%
Human Immunodeficiency Virus 1
18%
Clinical Trial
18%
Therapeutic Vaccine
18%
Neutralizing Antibody
18%
Infection
13%
Romidepsin
13%
Lefitolimod
10%
Human Immunodeficiency Virus 1 Infection
9%
RNA-Sequencing
9%
Aciclovir
9%
Transcriptome
9%
Histone
9%
Antivirus Agent
9%
Biochemistry, Genetics and Molecular Biology
Human Immunodeficiency Virus 1
21%
DNA Methylation
18%
Epigenetics
18%
Treatment Interruption
18%
Plasmacytoid Dendritic Cell
18%
Single-Cell Analysis
18%
Clinical Trial
18%
Romidepsin
9%
Rebound
9%
Human Immunodeficiency Virus
9%
T Cell
8%
Virus Load
6%
Histone
6%
Transcriptomics
5%